Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Parkinson’s Disease: Shared Inflammatory Pathways Under Oxidative Stress
Zahara L. Chaudhry, Donika Klenja, Najma A. Janjua, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 807-807
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Parkinson’s Disease and the COVID-19 Pandemic
Conor Fearon, Alfonso Fasano
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 431-444
Open Access | Times Cited: 84
Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic
Saikat Dewanjee, V. Jayalakshmi, Rajkumar Singh Kalra, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 9, pp. 4694-4715
Open Access | Times Cited: 65
Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease
Sachchida Nand, Neeraj Tiwari, Payal Singh, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 45
Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review
Yun Zhao, Ying Tang, Qi Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy
Thelma Akanchise, Angelina Angelova
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1562-1562
Open Access | Times Cited: 17
Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease
Tingting Liu, Haojie Wu, Lin Sun, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3259-3282
Open Access | Times Cited: 5
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Lea Krey, Meret K. Huber, Günter U. Höglinger, et al.
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1654-1654
Open Access | Times Cited: 28
Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
В. Н. Даниленко, A. V. Devyatkin, М. В. Марсова, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6349-6381
Open Access | Times Cited: 23
Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Dimitrios S. Mysiris, George D. Vavougios, Eirini Karamichali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9739-9739
Open Access | Times Cited: 16
Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
Jaime R. Silva, Felipe Patricio, Aleidy Patricio-Martínez, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery
Yu Wu, Miora Rakotoarisoa, Borislav Angelov, et al.
Nanomaterials (2022) Vol. 12, Iss. 13, pp. 2267-2267
Open Access | Times Cited: 12
COVID-19 related neurological manifestations in Parkinson’s disease: has ferroptosis been a suspect?
Fengju Jia, Jing Han
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
Salvatore Iacono, Giuseppe Schirò, Chiara Davì, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies
Yu Wu, Borislav Angelov, Yuru Deng, et al.
Communications Chemistry (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Parkinson’s Disease in Light of the COVID-19 Pandemic
Anna Drelich‐Zbroja, Mateusz Cheda, Maryla Kuczyńska, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 143-143
Open Access | Times Cited: 8
Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review
Jeremy M. Morowitz, Kaylyn Pogson, Daniel Roque, et al.
Brain Sciences (2022) Vol. 12, Iss. 5, pp. 536-536
Open Access | Times Cited: 8
Does COVID-19 Trigger the Risk for the Development of Parkinson’s Disease? Therapeutic Potential of Vitamin C
Sandeep, Rhea Subba, Amal Chandra Mondal
Molecular Neurobiology (2023) Vol. 61, Iss. 12, pp. 9945-9960
Closed Access | Times Cited: 4
Implications of COVID-19 in Parkinson’s disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration
Júlia Leão Batista Simões, Geórgia de Carvalho Braga, Samantha Webler Eichler, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 487-507
Closed Access | Times Cited: 1
Dialogue between Neuroinflammation and Neurodegenerative Diseases in COVID-19
Bisruta Chowdhury, Apoorva Sharma, Sairaj Satarker, et al.
Journal of Environmental Pathology Toxicology and Oncology (2021) Vol. 40, Iss. 3, pp. 37-49
Open Access | Times Cited: 9
ER Stress in COVID-19 and Parkinson’s Disease: In Vitro and In Silico Evidences
Zahara L. Chaudhry, Mahmoud Gamal, Ingrid Ferhati, et al.
Brain Sciences (2022) Vol. 12, Iss. 4, pp. 507-507
Open Access | Times Cited: 5
The peripheral and core regions of virus-host network of COVID-19
Bingbo Wang, Xianan Dong, Jie Hu, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 4
MONFIT: Multi-omics factorization-based integration of time-series data sheds light on Parkinson's disease
Katarina Mihajlović, Noël Malod‐Dognin, Corrado Ameli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
MONFIT: multi-omics factorization-based integration of time-series data sheds light on Parkinson’s disease
Katarina Mihajlović, Noël Malod‐Dognin, Corrado Ameli, et al.
Deleted Journal (2024) Vol. 1, Iss. 4
Open Access
Inhaling dementia: Environmental toxins, Alzheimer’s disease, and Parkinson’s disease
Marissa A. Harrison
The Social Science Journal (2024), pp. 1-12
Open Access
Exploring the relationship between novel Coronavirus pneumonia and Parkinson’s disease
Xiaoming Xi, Liang Han
Medicine (2022) Vol. 101, Iss. 46, pp. e31813-e31813
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top